SCHEMBL7880841

SCHEMBL7880841

CN(C)Cc1ccc(Oc2ccc(Cl)c3cc(C(=O)N(C)C(=N)N)[nH]c23)o1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
ACHE P22303 1/20 0.33
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882398 0.92
SCHEMBL7873968 0.91 KDM4E (0.31) KDM4EHPGD
SCHEMBL7880847 0.88 SLC6A2 (0.31) SLC6A4
SCHEMBL7879720 0.88 MAPT (0.37) HTR2ASLC6A4ACHE
SCHEMBL7878021 0.86 KDM4E (0.33) KDM4E
SCHEMBL7880785 0.84 AR (0.41) KDM4EHPGD
SCHEMBL7882020 0.83 SLC6A4 (0.45) HTR2ASLC6A4
SCHEMBL7880844 0.83 ACHE (0.33) HTR2ASLC6A4ACHE
SCHEMBL7881961 0.82 HTR2A (0.33) HTR2ASLC6A4
SCHEMBL7880791 0.82 RHEB (0.33) HTR2ASLC6A4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed